219 related articles for article (PubMed ID: 32657564)
1. Simultaneous Single-Particle Tracking and Dynamic pH Sensing Reveal Lysosome-Targetable Mesoporous Silica Nanoparticle Pathways.
Zhang RL; Pratiwi FW; Chen BC; Chen P; Wu SH; Mou CY
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42472-42484. PubMed ID: 32657564
[TBL] [Abstract][Full Text] [Related]
2. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.
Gurka MK; Pender D; Chuong P; Fouts BL; Sobelov A; McNally MW; Mezera M; Woo SY; McNally LR
J Control Release; 2016 Jun; 231():60-7. PubMed ID: 26763377
[TBL] [Abstract][Full Text] [Related]
3. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
[TBL] [Abstract][Full Text] [Related]
4. Surface pH buffering to promote degradation of mesoporous silica nanoparticles under a physiological condition.
Choi E; Kim S
J Colloid Interface Sci; 2019 Jan; 533():463-470. PubMed ID: 30172772
[TBL] [Abstract][Full Text] [Related]
5. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
7. Selective tracking of lysosomal Cu2+ ions using simultaneous target- and location-activated fluorescent nanoprobes.
Li Y; Zhao Y; Chan W; Wang Y; You Q; Liu C; Zheng J; Li J; Yang S; Yang R
Anal Chem; 2015 Jan; 87(1):584-91. PubMed ID: 25435382
[TBL] [Abstract][Full Text] [Related]
8. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
9. Local pH tracking in living cells.
Tsou CJ; Hsia CH; Chu JY; Hung Y; Chen YP; Chien FC; Chou KC; Chen P; Mou CY
Nanoscale; 2015 Mar; 7(9):4217-25. PubMed ID: 25672786
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
11. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
[TBL] [Abstract][Full Text] [Related]
13. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
16. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
17. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
19. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
20. A lysosome-targeting nanosensor for simultaneous fluorometric imaging of intracellular pH values and temperature.
Zhang W; Abou El-Reash YG; Ding L; Lin Z; Lian Y; Song B; Yuan J; Wang XD
Mikrochim Acta; 2018 Nov; 185(12):533. PubMed ID: 30402697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
